Kurtz Ronald M MD 4
4 · RxSight, Inc. · Filed Dec 18, 2023
Insider Transaction Report
Form 4
RxSight, Inc.RXST
Kurtz Ronald M MD
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2023-12-14$39.40/sh−20,000$788,022→ 889,610 total(indirect: See footnote) - Sale
Common Stock
2023-12-14$40.01/sh−20,000$800,164→ 909,610 total(indirect: See footnote)
Holdings
- 40,000
Common Stock
Footnotes (4)
- [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 15, 2023 by the Reporting Person.
- [F2]Represents the weighted average share price of an aggregate total of 20,000 shares sold in the price range of $39.5268 to $40.405 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Shares held by Cricklewood LP. The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse.
- [F4]Represents the weighted average share price of an aggregate total of 20,000 shares sold in the price range of $39.08 to $39.87 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.